Venture-Backed Startups

Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.

3 investors

Epiroc develops and supplies equipment for mining and infrastructure customers, including drill rigs, rock excavation and construction equipment, and related tools for surface and underground applications. It also provides aftermarket service and support along with automation, digitalization, and electrification solutions.

1 investor

Epirus develops high-power microwave systems and electronic warfare technology for defense applications, including counter-unmanned aircraft systems for the U.S. military. The company serves government defense agencies and offers contracting vehicles and prototype solutions for advanced defense capabilities.

8 investors

1 investor

0 investors

EpiSci develops autonomy software and infrastructure for military applications across land, air, sea, space, and spectrum domains. Its products include the Axion toolchain and Acuity onboard software layer, which support autonomous systems across multiple platforms and mission sets for defense and warfighter use.

1 investor

EpiSensor manufactures rugged embedded computers and wireless sensors that enable enterprise customers to monitor energy use, environmental conditions, and asset performance across commercial and industrial sites. The company provides device management software and visual programming tools for IoT applications focused on energy efficiency and sustainability.

2 investors

Epishine develops thin, flexible organic indoor solar cells that power low-energy devices using ambient and artificial light. The company serves manufacturers integrating maintenance-free power solutions into consumer electronics, remote controls, asset trackers, and electronic shelf labels.

1 investor

Studio Episode is a Korean content studio run by content specialists who create YouTube channels and produce viral video content. The company also offers advertising partnerships and content production services.

1 investor

Episode Six provides a card issuing and ledger infrastructure platform that lets banks, fintechs, and brands configure and launch payment products such as credit, debit, prepaid, commercial, and virtual cards, along with deposit and lending products. The platform offers real-time control over interest rates, fees, and risk settings through a permission-based dashboard.

1 investor

0 investors

Episode 1 is a venture capital firm founded and operated by experienced founders and investors who provide capital and operational support to early-stage startups, with particular focus on AI-driven deals.

3 investors

0 investors

Epistemic AI automates strategic intelligence deliverables for life sciences companies, including competitive landscapes, target product profiles, and conference analysis. The platform uses AI-powered automation validated by life science experts to deliver structured, evidence-backed strategic documents traditionally requiring months of consulting work.

2 investors

Epistemix builds an individual-level simulation platform that models how products get adopted across a market, letting organizations test strategies, run scenarios, and track execution against forecasts. It serves businesses seeking to understand and optimize product adoption and viral growth.

2 investors

Epitel is a digital health company that builds REMI, a wearable, wireless cloud-based EEG monitoring system with AI-based seizure event detection for use in healthcare and ambulatory settings. Its FDA-cleared platform serves physicians and patients (adult and pediatric) needing remote electrographic seizure monitoring in the U.S.

3 investors

Epitomee Medical develops the Epitomee Capsule, a medical device for weight management solutions. The company brings together experts in medical technology and clinical research to address health outcomes.

1 investor

Epitomee develops ingestible therapeutic devices and platforms that deliver targeted therapies along the gastrointestinal tract to manage metabolic diseases, obesity, and deliver biologics. The company combines mechanical and ingestible morphology platforms with therapeutic agents to achieve specific localization with limited side effects.

2 investors

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.

3 investors

Epivara is developing an injectable, permanent alternative to surgical spay and neuter procedures for mammals, intended to be administered in a single shot without anesthesia or incisions. Its products (iSpay, iNeuter, and iNeuter-S) target pets such as cats and dogs, small animals, and livestock in the meat industry to control reproduction and reduce hormone-related issues like boar taint.

1 investor

EpiVario is a biotechnology company developing small-molecule ACSS2 inhibitors that target a neuroepigenetic process involved in long-term memory formation, aimed at treating PTSD and substance use disorders. Spun out of the University of Pennsylvania's Epigenetics Institute, it develops pharmacotherapeutics for memory-related psychiatric and addiction disorders.

0 investors

0 investors

EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.

3 investors

ePlane AI provides a modular agentic AI platform with agents for decision-making, inventory optimization, RFQ email automation, and operations planning, built on experience automating aviation operations. It serves enterprises in aerospace, manufacturing, AEC, life sciences, and other complex operational and supply chain environments.

1 investor